Tipos de interés EEUU en 2025: "La Fed no hará ningún recorte de tipos en el primer año de Trump
- 36
Estrategias de inversión
Lastest news
- ROSEN, TRUSTED INVESTOR COUNSEL, Encourages TransMedics Group, Inc. Investors to Inquire About Securities Class Action Investigation - TMDX
- $HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of 180 Degree Capital Corp. - TURN
- Sensient Declares Dividend
- DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Applied Therapeutics
- DATROWAY® (datopotamab deruxtecan-dlnk) approved in the US for patients with previously treated metastatic HR-positive, HER2-negative breast cancer
- DATROWAY® Approved in the U.S. for Patients with Previously Treated Metastatic HR Positive, HER2 Negative Breast Cancer
Lastest videos
